The Problem
Nowhere is the deception of counterfeiters more dangerous than in pharmaceuticals, where consumers literally trust their lives to brand authenticity based on packaging.  The package that contains the medication has become the guarantee that the product within is genuine.

Counterfeiters exploit this trust mercilessly. They spend heavily on advanced digital reproduction technologies to produce virtually perfect reproductions of pharmaceutical packaging – and fill them with worthless, but sometimes harmful ingredients that appear to be genuine pills, tablets, capsules or liquid medications. 

The Solution
IDGLOBAL’s integrated solutions enable distributors and pharmacies to quickly and easily authenticate pharmaceutical packaging with 100% accuracy – and therefore the authenticity of the product within. IDGLOBAL’s uniquely effective  combination of customized Nano-Molecular Markers™ and multi-layer track and trace technologies to safeguard consumers health – and producer’s legitimate profits - at every point in the supply chain.

The Result
By enabling the detection and interdiction denying of fraudulent pharmaceutical packaging, IDGLOBAL effectively raises the barrier to entry to brand identity theft in this market and largely eliminates the opportunity to substitute worthless and or harmful substances for genuine medication. IDGLOBAL solutions protect consumer trust in the products the packaging carries – and ultimately their health - as well as the ability of producers to carry on their business with confidence.

ATL and IDGLOBAL Partnership

IDGLOBAL has secured an unprecedented ten (10) year contract to supply its Nano-Molecular Marking, anti-counterfeiting technology, to the renowned pharmaceutical labeling corporation ATL Pharma Security Label Systems (www.atlco.com), a division of Ad Tape & Label Co. This 10 year supply contract guarantees ATL the ability to incorporate IDGLOBAL's Nano-Molecular Marking technologies into any of ATLs Pharmaceutical labeling solutions to provide its clients the highest level of protection against counterfeited labels.

ATL is one of the worlds leading secure label solutions providers, manufacturing more than half of all pharmaceutical clinical trial labels for most of the major Pharmaceutical corporations. In the past 7 years ATL has produced more than 120 million pharmaceutical labels (including 19 page booklets), in over 80 languages, for over 1700 clinical trials. In business since 1951, ATL is an FDA Registered Medical Device manufacturer that also specializes in private brand disposable medical device manufacturing. See attached link Pharmaceutical Counterfeiting for more information: http://www.atlco.com/medical/PharmaAntiCounterfeiting.html

See Press Release for additional information